- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Morepen Laboratories Limited has approved the hiving off of its Medical Devices Business to its subsidiary, Morepen Medtech Limited, on a slump sale basis as a going concern, pending necessary regulatory and member approvals. For the financial year ending March 31, 2024, the Medical Devices Business contributed ₹44,271.59 Cr in turnover, representing 26.19% of the company's total, and ₹9,078.52 Cr in net worth, or 10.88%. The expected completion date for the sale is on or before September 30, 2025. This strategic move aims to enhance focus and operational independence for the medical devices segment.